Bengaluru, India, July 04, 2018
“Biocon has received the EU GMP certification for its Sterile Drug Product manufacturing facility in Bangalore, which was inspected by the European agencies in March 2018. This facility is used for the manufacture of Biocon’s portfolio of biosimilars. Biocon remains committed to global standards of quality and compliance.”
– Company Spokesperson
You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.